fluspirilene has been researched along with Obsessive-Compulsive Disorder in 1 studies
Fluspirilene: A long-acting injectable antipsychotic agent used for chronic schizophrenia.
Obsessive-Compulsive Disorder: An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension.
| Excerpt | Relevance | Reference |
|---|---|---|
| " There is a difference between all three dosage groups after 6 weeks." | 2.66 | The dose-effect relationship of 0.5, 1.0 and 1.5 mg fluspirilene on anxious patients. ( Lehmann, E, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lehmann, E | 1 |
1 trial available for fluspirilene and Obsessive-Compulsive Disorder
| Article | Year |
|---|---|
The dose-effect relationship of 0.5, 1.0 and 1.5 mg fluspirilene on anxious patients.
Topics: Adult; Aged; Anxiety Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Flusp | 1989 |